Literature DB >> 21079424

Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening.

Gavin J Churchyard1, Katherine L Fielding, James J Lewis, Violet N Chihota, Yasmeen Hanifa, Alison D Grant.   

Abstract

OBJECTIVE: This analysis describes the prevalence of and risk factors for tuberculosis at screening prior to isoniazid preventive therapy (IPT); the additional yield of tuberculosis using chest radiography versus symptoms alone, and risk factors for tuberculosis missed by screening.
DESIGN: Cross-sectional analysis of a trial of community-wide IPT in South African gold mines.
METHODS: Participants were screened for tuberculosis prior to starting IPT using symptoms (cough >2 weeks, weight loss, night sweats) and chest radiography. Tuberculosis suspects had sputum collected for mycobacterial investigations. Those with a positive smear or culture with no speciation or culture identified as Mycobacterium tuberculosis were classified as having probable or definite tuberculosis, respectively. Among participants who were dispensed IPT, we defined a 'missed' case of active tuberculosis as one identified within 90 days of the enrolment screen.
RESULTS: Between July 2006 and December 2008, among 23,286 participants with complete data, the prevalence of undiagnosed tuberculosis [definite (284) and probable (31)] was high (315/23 286; 1.4%). The addition of chest radiography to symptom screening increased the number of definite tuberculosis cases detected by 2.5-fold (113 to 281 cases). Among 19,609 individuals correctly screened for tuberculosis who started IPT and had more than 90 days of follow-up, only 39 (0.2%) active tuberculosis cases were missed. Risk factors for tuberculosis missed by screening included increasing age [adjusted odds ratio (aOR) 1.66/10 year increase, 95% confidence interval (CI) 1.07-2.56], non-South African, in HIV care (aOR 4.80, 95% CI 1.63-14.1), lower weight (aOR 2.07/10 kg decrease, 95% CI 1.23-3.49) and alcohol use (aOR 2.52, 95% CI 1.31-4.86), which were similar to risk factors for tuberculosis detected by screening.
CONCLUSION: Tuberculosis screening prior to IPT detects a substantial burden of tuberculosis and misses very few cases. Chest radiography significantly increased the yield of tuberculosis cases detected.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21079424     DOI: 10.1097/01.aids.0000391018.72542.46

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  13 in total

Review 1.  Tuberculosis and HIV co-infection: screening and treatment strategies.

Authors:  Kartik K Venkatesh; Soumya Swaminathan; Jason R Andrews; Kenneth H Mayer
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

2.  Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa.

Authors:  Susan E Dorman; Violet N Chihota; James J Lewis; Minty van der Meulen; Barun Mathema; Natalie Beylis; Katherine L Fielding; Alison D Grant; Gavin J Churchyard
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

3.  Number needed to screen for TB in clinical, structural or occupational risk groups.

Authors:  F Naufal; L H Chaisson; K O Robsky; P Delgado-Barroso; H S Alvarez-Manzo; C R Miller; A E Shapiro; J E Golub
Journal:  Int J Tuberc Lung Dis       Date:  2022-06-01       Impact factor: 3.427

4.  Community-wide isoniazid preventive therapy drives drug-resistant tuberculosis: a model-based analysis.

Authors:  Harriet L Mills; Ted Cohen; Caroline Colijn
Journal:  Sci Transl Med       Date:  2013-04-10       Impact factor: 17.956

Review 5.  Diagnosis & treatment of tuberculosis in HIV co-infected patients.

Authors:  C Padmapriyadarsini; G Narendran; Soumya Swaminathan
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

Review 6.  Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status.

Authors:  Anja Van't Hoog; Kerri Viney; Olivia Biermann; Bada Yang; Mariska Mg Leeflang; Miranda W Langendam
Journal:  Cochrane Database Syst Rev       Date:  2022-03-23

7.  Clinical Relevance of Nontuberculous Mycobacteria Isolated from Sputum in a Gold Mining Workforce in South Africa: An Observational, Clinical Study.

Authors:  Clare L van Halsema; Violet N Chihota; Nicolaas C Gey van Pittius; Katherine L Fielding; James J Lewis; Paul D van Helden; Gavin J Churchyard; Alison D Grant
Journal:  Biomed Res Int       Date:  2015-05-28       Impact factor: 3.411

8.  Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis.

Authors:  Daniel E Winetsky; Diana M Negoescu; Emilia H DeMarchis; Olga Almukhamedova; Aizhan Dooronbekova; Dilshod Pulatov; Natalia Vezhnina; Douglas K Owens; Jeremy D Goldhaber-Fiebert
Journal:  PLoS Med       Date:  2012-11-27       Impact factor: 11.069

9.  Screening strategies for tuberculosis prevalence surveys: the value of chest radiography and symptoms.

Authors:  Anna H van't Hoog; Helen K Meme; Kayla F Laserson; Janet A Agaya; Benson G Muchiri; Willie A Githui; Lazarus O Odeny; Barbara J Marston; Martien W Borgdorff
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

10.  Eligibility for isoniazid preventive therapy in South African gold mines.

Authors:  James J Lewis; Katherine L Fielding; Alison D Grant; Violet N Chihota; Flora Popane; Mariette Luttig; Dorothy Muller; Leonie Coetzee; Gavin J Churchyard
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.